A. anti CD3 antibody
B. anti CD25 antibody
C. IL1 receptor antagonist
D. TNF alpha inhibitor
Correct answer : B. anti CD25 antibody
- Basiliximab is an anti CD25 antibody.
- It has high affinity for interleukin 2 receptor.
- Plasma half life is shorter (1 week) compared to Daclizumab (3 weeks).
- It is used for the prevention of rejection reactions in transplant patients.
Ref: Essentials of Medical Pharmacology, K D Tripathi, 7th ed, p878, 884.